Caprotec Bioanalytics
caprotec bioanalytics developed a proprietary capture protein technology to reduce the complexity of protein mixtures and samples.
Caprotec Bioanalytics has raised €14M across 3 funding rounds from 2 investors, most recently a round in May 2011. Based in Berlin, Germany; founded 2007. Data as of 28 Oct 2026.
Total raised
€14M
€14,400,000
Funding rounds
3
Investors
2
distinct backers
Active since
2008-01
latest 2011-05
Funding by year
EUR raised per yearCaprotec Bioanalytics — funding by year — interactive chart.
Data table
| Caprotec Bioanalytics — funding by year | |
|---|---|
| 2007 | €7.9M |
| 2010 | €4.6M |
| 2011 | €1.9M |
Signals
Medium confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2011-05-01 | Other | €1.9M | — | View deal → |
| 2010-05-01 | Other | €4.6M | IBB Beteiligungsgesellschaft | View deal → |
| 2008-01-01 | Other | €7.9M | Creathor Venture | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData